By clicking above image, you can go to original article in The Asahi Shimbun
The health ministry gave the go-ahead Feb. 18 for the world’s first clinical trial of human induced pluripotent stem (iPS) cells to treat spinal cord injuries, raising hopes for those with the chronic condition.